S
Santanu Samanta
Assistant Professor
faculty
COM | Radiation Oncology Faculty
14 h-index
62 pubs
675 cited
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Santanu Samanta's research focuses on the application of radiation oncology and related treatment modalities for various cancers. His work includes investigating biomarkers for radiation resistance in lung cancer and assessing the dose distribution of radiation dermatitis in head and neck cancers. Samanta has also explored outcomes of different conditioning regimens for allogeneic stem cell transplantation in patients with hematologic diseases and examined spatially fractionated radiation therapy for head and neck malignancies. Additionally, his research interests extend to the use of virtual reality technology for brachytherapy training and delivery. Samanta has published 69 papers, with an h-index of 14 and a total of 666 citations. He collaborates with researchers at the University of Arkansas for Medical Sciences, including Gary D. Lewis, R.J. Megahed, Mausam Patel, and Richard L. Crownover.
Metrics
- h-index: 14
- Publications: 62
- Citations: 675
Selected Publications
-
Evaluation of dosimetric variations from anatomical changes in head and neck cancer patients treated with intensity modulated proton therapy (2026)
-
Liver-Sparing Total Body Irradiation Using Helical Tomotherapy for Relapsed Pre-B-cell Acute Lymphoblastic Leukemia (2025)
-
ARTIA-Cervix: a prospective trial of adaptive radiation therapy for cervical cancer (2025)
-
Intensity Modulated Proton Therapy with Robust Optimization to Mitigate Inter-Fractional Variations (2025)
-
Utilizing in-Room Cone-Beam CT to Streamline Gynecological Brachytherapy Workflow (2025)
-
P0114 (2025)
-
Medical Student Satisfaction Scores after Establishment of a Third-Year Medical School Elective Rotation in Radiation Oncology (2025)
-
Summer Educational Program to Recruit First Year Medical Students into an Oncology Specialty (2025)
-
GSOR10 Presentation Time: 12:15 PM (2024)
-
GSOR03 Presentation Time: 5:10 PM (2024)
-
Spatially Fractionated Radiation Therapy for Bulky Head and Neck Malignancies: A Single Institution Experience (2024)
-
Reirradiation in head and neck squamous cell carcinoma; prognostic indicators, oncologic and functional outcomes (2024)
-
Planning strategy on delivery robustness of intensity modulated proton therapy to treat patients with head-neck cancers (2024)
-
Re-irradiation of recurrent head and neck cancers using pulsed reduced dose rate radiotherapy: An institutional series (2024)
-
One Year Experience of a Radiation Oncology Semi-weekly Head & Neck Contour Peer Review at a Single Institution (2024)
Collaboration Network
Top Collaborators
Gary D. Lewis
The University of Texas MD Anderson Cancer Center
12 shared publications
In database
- Virtual reality technology: A potential tool to enhance brachytherapy training and delivery
- Spatially Fractionated Radiation Therapy for Bulky Head and Neck Malignancies: A Single Institution Experience
- Re-Irradiation of Recurrent Head and Neck Cancers Using Pulsed Reduced Dose Rate Radiotherapy: An Institutional Series
- One Year Experience of a Radiation Oncology Semi-weekly Head & Neck Contour Peer Review at a Single Institution
- Re-irradiation of recurrent head and neck cancers using pulsed reduced dose rate radiotherapy: An institutional series
Showing 5 of 12 shared publications
R.J. Megahed
University of Arkansas for Medical Sciences
7 shared publications
In database
- Spatially Fractionated Radiation Therapy for Bulky Head and Neck Malignancies: A Single Institution Experience
- Re-Irradiation of Recurrent Head and Neck Cancers Using Pulsed Reduced Dose Rate Radiotherapy: An Institutional Series
- One Year Experience of a Radiation Oncology Semi-weekly Head & Neck Contour Peer Review at a Single Institution
- Re-irradiation of recurrent head and neck cancers using pulsed reduced dose rate radiotherapy: An institutional series
- P0114
Showing 5 of 7 shared publications
Jason K. Molitoris
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
5 shared publications
- The impact of bridging therapy prior to CD19‐directed chimeric antigen receptor T‐cell therapy in patients with large B‐cell lymphoma
- Outcomes of Busulfan, Fludarabine, and 400 cGy Total Body Irradiation Compared With Busulfan and Fludarabine Reduced-Intensity Conditioning Regimens for Allogeneic Stem Cell Transplantation in Adult Patients With Hematologic Diseases: A Single-Center Experience
- The Impact of Bridging Therapy Prior to CAR-T Cell Therapy on Clinical Outcomes of Patients with Relapsed Refractory Large B-Cell Lymphoma
- PO36
- Racial Analysis of Clinical and Biochemical Outcomes in Patients With Prostate Cancer Treated With Low-Dose-Rate Brachytherapy
Mausam Patel
University of Arkansas for Medical Sciences (US)
5 shared publications
- Re-Irradiation of Recurrent Head and Neck Cancers Using Pulsed Reduced Dose Rate Radiotherapy: An Institutional Series
- One Year Experience of a Radiation Oncology Semi-weekly Head & Neck Contour Peer Review at a Single Institution
- Re-irradiation of recurrent head and neck cancers using pulsed reduced dose rate radiotherapy: An institutional series
- Planning strategy on delivery robustness of intensity modulated proton therapy to treat patients with head-neck cancers
- Medical Student Satisfaction Scores after Establishment of a Third-Year Medical School Elective Rotation in Radiation Oncology
Pranshu Mohindra
4 shared publications
- The impact of bridging therapy prior to CD19‐directed chimeric antigen receptor T‐cell therapy in patients with large B‐cell lymphoma
- Outcomes of Busulfan, Fludarabine, and 400 cGy Total Body Irradiation Compared With Busulfan and Fludarabine Reduced-Intensity Conditioning Regimens for Allogeneic Stem Cell Transplantation in Adult Patients With Hematologic Diseases: A Single-Center Experience
- The Impact of Bridging Therapy Prior to CAR-T Cell Therapy on Clinical Outcomes of Patients with Relapsed Refractory Large B-Cell Lymphoma
- Integrating Immunotherapy and Targeted Therapy with Radiation Therapy
Arpan V. Prabhu
Indiana University (US)
4 shared publications
- Virtual reality technology: A potential tool to enhance brachytherapy training and delivery
- Re-Irradiation of Recurrent Head and Neck Cancers Using Pulsed Reduced Dose Rate Radiotherapy: An Institutional Series
- Re-irradiation of recurrent head and neck cancers using pulsed reduced dose rate radiotherapy: An institutional series
- Medical Student Satisfaction Scores after Establishment of a Third-Year Medical School Elective Rotation in Radiation Oncology
Anam Kesaria
Scripps MD Anderson Cancer Center (US)
4 shared publications
- Virtual reality technology: A potential tool to enhance brachytherapy training and delivery
- GSOR03 Presentation Time: 5:10 PM
- GSOR10 Presentation Time: 12:15 PM
- Medical Student Satisfaction Scores after Establishment of a Third-Year Medical School Elective Rotation in Radiation Oncology
Forat Lutfi
University of Maryland, Baltimore (US)
3 shared publications
- The impact of bridging therapy prior to CD19‐directed chimeric antigen receptor T‐cell therapy in patients with large B‐cell lymphoma
- Outcomes of Busulfan, Fludarabine, and 400 cGy Total Body Irradiation Compared With Busulfan and Fludarabine Reduced-Intensity Conditioning Regimens for Allogeneic Stem Cell Transplantation in Adult Patients With Hematologic Diseases: A Single-Center Experience
- The Impact of Bridging Therapy Prior to CAR-T Cell Therapy on Clinical Outcomes of Patients with Relapsed Refractory Large B-Cell Lymphoma
Moaath K. Mustafa Ali
University of Maryland, Baltimore (US)
3 shared publications
- The impact of bridging therapy prior to CD19‐directed chimeric antigen receptor T‐cell therapy in patients with large B‐cell lymphoma
- Outcomes of Busulfan, Fludarabine, and 400 cGy Total Body Irradiation Compared With Busulfan and Fludarabine Reduced-Intensity Conditioning Regimens for Allogeneic Stem Cell Transplantation in Adult Patients With Hematologic Diseases: A Single-Center Experience
- The Impact of Bridging Therapy Prior to CAR-T Cell Therapy on Clinical Outcomes of Patients with Relapsed Refractory Large B-Cell Lymphoma
Ali Bukhari
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
3 shared publications
- The impact of bridging therapy prior to CD19‐directed chimeric antigen receptor T‐cell therapy in patients with large B‐cell lymphoma
- Outcomes of Busulfan, Fludarabine, and 400 cGy Total Body Irradiation Compared With Busulfan and Fludarabine Reduced-Intensity Conditioning Regimens for Allogeneic Stem Cell Transplantation in Adult Patients With Hematologic Diseases: A Single-Center Experience
- The Impact of Bridging Therapy Prior to CAR-T Cell Therapy on Clinical Outcomes of Patients with Relapsed Refractory Large B-Cell Lymphoma
Mehmet H. Kocoglu
3 shared publications
- The impact of bridging therapy prior to CD19‐directed chimeric antigen receptor T‐cell therapy in patients with large B‐cell lymphoma
- Outcomes of Busulfan, Fludarabine, and 400 cGy Total Body Irradiation Compared With Busulfan and Fludarabine Reduced-Intensity Conditioning Regimens for Allogeneic Stem Cell Transplantation in Adult Patients With Hematologic Diseases: A Single-Center Experience
- The Impact of Bridging Therapy Prior to CAR-T Cell Therapy on Clinical Outcomes of Patients with Relapsed Refractory Large B-Cell Lymphoma
Jean A. Yared
3 shared publications
- The impact of bridging therapy prior to CD19‐directed chimeric antigen receptor T‐cell therapy in patients with large B‐cell lymphoma
- Outcomes of Busulfan, Fludarabine, and 400 cGy Total Body Irradiation Compared With Busulfan and Fludarabine Reduced-Intensity Conditioning Regimens for Allogeneic Stem Cell Transplantation in Adult Patients With Hematologic Diseases: A Single-Center Experience
- The Impact of Bridging Therapy Prior to CAR-T Cell Therapy on Clinical Outcomes of Patients with Relapsed Refractory Large B-Cell Lymphoma
Nancy M. Hardy
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
3 shared publications
- The impact of bridging therapy prior to CD19‐directed chimeric antigen receptor T‐cell therapy in patients with large B‐cell lymphoma
- Outcomes of Busulfan, Fludarabine, and 400 cGy Total Body Irradiation Compared With Busulfan and Fludarabine Reduced-Intensity Conditioning Regimens for Allogeneic Stem Cell Transplantation in Adult Patients With Hematologic Diseases: A Single-Center Experience
- The Impact of Bridging Therapy Prior to CAR-T Cell Therapy on Clinical Outcomes of Patients with Relapsed Refractory Large B-Cell Lymphoma
Aaron P. Rapoport
University of Maryland, Baltimore (US)
3 shared publications
- The impact of bridging therapy prior to CD19‐directed chimeric antigen receptor T‐cell therapy in patients with large B‐cell lymphoma
- Outcomes of Busulfan, Fludarabine, and 400 cGy Total Body Irradiation Compared With Busulfan and Fludarabine Reduced-Intensity Conditioning Regimens for Allogeneic Stem Cell Transplantation in Adult Patients With Hematologic Diseases: A Single-Center Experience
- The Impact of Bridging Therapy Prior to CAR-T Cell Therapy on Clinical Outcomes of Patients with Relapsed Refractory Large B-Cell Lymphoma
Saurabh Dahiya
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
3 shared publications
- The impact of bridging therapy prior to CD19‐directed chimeric antigen receptor T‐cell therapy in patients with large B‐cell lymphoma
- Outcomes of Busulfan, Fludarabine, and 400 cGy Total Body Irradiation Compared With Busulfan and Fludarabine Reduced-Intensity Conditioning Regimens for Allogeneic Stem Cell Transplantation in Adult Patients With Hematologic Diseases: A Single-Center Experience
- The Impact of Bridging Therapy Prior to CAR-T Cell Therapy on Clinical Outcomes of Patients with Relapsed Refractory Large B-Cell Lymphoma
Similar Researchers
Based on overlapping research topics
F. Kalantari
University of Arkansas for Medical Sciences
Radiation Therapy and Dosimetry
Head and Neck Cancer Studies
Surgical Simulation and Training
Zainal Ariff Abdul Rahman
University of Arkansas at Fayetteville
Head and Neck Cancer Studies
Cancer Immunotherapy and Biomarkers
Surgical Simulation and Training
Macie Cain
University of Arkansas for Medical Sciences
Head and Neck Cancer Studies
Surgical Simulation and Training
Kayla Schneider
University of Arkansas for Medical Sciences
Radiation Therapy and Dosimetry
Head and Neck Cancer Studies
Somayeh Gholami
University of Arkansas for Medical Sciences
Radiation Therapy and Dosimetry
Head and Neck Cancer Studies
Ebone Bady
University of Arkansas at Fayetteville
Head and Neck Cancer Studies
Surgical Simulation and Training